These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 36615841)

  • 21. Treatment of Diabetic Kidney Disease: Current and Future.
    Yamazaki T; Mimura I; Tanaka T; Nangaku M
    Diabetes Metab J; 2021 Jan; 45(1):11-26. PubMed ID: 33508907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal hemodynamic changes in patients with type 2 diabetes and their clinical impact.
    Saulnier PJ; Bjornstad P
    Presse Med; 2023 Mar; 52(1):104175. PubMed ID: 37783424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diabetic kidney disease: from physiology to therapeutics.
    Mora-Fernández C; Domínguez-Pimentel V; de Fuentes MM; Górriz JL; Martínez-Castelao A; Navarro-González JF
    J Physiol; 2014 Sep; 592(18):3997-4012. PubMed ID: 24907306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Harnessing Metabolomics to Describe the Pathophysiology Underlying Progression in Diabetic Kidney Disease.
    Hasegawa S; Inagi R
    Curr Diab Rep; 2021 May; 21(7):21. PubMed ID: 33974145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin resistance, diabetic kidney disease, and all-cause mortality in individuals with type 2 diabetes: a prospective cohort study.
    Penno G; Solini A; Orsi E; Bonora E; Fondelli C; Trevisan R; Vedovato M; Cavalot F; Zerbini G; Lamacchia O; Nicolucci A; Pugliese G;
    BMC Med; 2021 Mar; 19(1):66. PubMed ID: 33715620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sodium-Glucose Cotransporter-2 Inhibitors-Miracle Drugs for the Treatment of Chronic Kidney Disease Irrespective of the Diabetes Status: Lessons from the Dedicated Kidney Disease-Focused CREDENCE and DAPA-CKD Trials.
    Gohda T; Murakoshi M
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Update of pathophysiology and management of diabetic kidney disease.
    Lin YC; Chang YH; Yang SY; Wu KD; Chu TS
    J Formos Med Assoc; 2018 Aug; 117(8):662-675. PubMed ID: 29486908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gut microbiota and its metabolites - molecular mechanisms and management strategies in diabetic kidney disease.
    Mao ZH; Gao ZX; Liu DW; Liu ZS; Wu P
    Front Immunol; 2023; 14():1124704. PubMed ID: 36742307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term outcomes of patients with type 2 diabetes attending a multidisciplinary diabetes kidney disease clinic.
    Low S; Lim SC; Wang J; Yeoh LY; Liu YL; Lim EK; Shao YL; Chui W; Fun S; Chua CL; Subramaniam T; Sum CF
    J Diabetes; 2018 Jul; 10(7):572-580. PubMed ID: 29154443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin Sensitivity and Diabetic Kidney Disease in Children and Adolescents With Type 2 Diabetes: An Observational Analysis of Data From the TODAY Clinical Trial.
    Bjornstad P; Nehus E; El Ghormli L; Bacha F; Libman IM; McKay S; Willi SM; Laffel L; Arslanian S; Nadeau KJ;
    Am J Kidney Dis; 2018 Jan; 71(1):65-74. PubMed ID: 29157731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lower bile acids as an independent risk factor for renal outcomes in patients with type 2 diabetes mellitus and biopsy-proven diabetic kidney disease.
    Xiao X; Zhang J; Ji S; Qin C; Wu Y; Zou Y; Yang J; Zhao Y; Yang Q; Liu F
    Front Endocrinol (Lausanne); 2022; 13():1026995. PubMed ID: 36277729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glomerular cell cross talk in diabetic kidney diseases.
    Dong R; Xu Y
    J Diabetes; 2022 Aug; 14(8):514-523. PubMed ID: 35999686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of strict glycemic control on renal hemodynamic response to amino acids and renal enlargement in insulin-dependent diabetes mellitus.
    Tuttle KR; Bruton JL; Perusek MC; Lancaster JL; Kopp DT; DeFronzo RA
    N Engl J Med; 1991 Jun; 324(23):1626-32. PubMed ID: 2030719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetic Kidney Disease Back in Focus: Management Field Guide for Health Care Professionals in the 21st Century.
    Alicic R; Nicholas SB
    Mayo Clin Proc; 2022 Oct; 97(10):1904-1919. PubMed ID: 36202498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aortic stiffness and ambulatory blood pressure as predictors of diabetic kidney disease: a competing risks analysis from the Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CRL; Leite NC; Salles GC; Ferreira MT; Salles GF
    Diabetologia; 2018 Feb; 61(2):455-465. PubMed ID: 29063128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intestinal microbiome diversity of diabetic and non-diabetic kidney disease: Current status and future perspective.
    Das S; Gnanasambandan R
    Life Sci; 2023 Mar; 316():121414. PubMed ID: 36682521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacotherapeutic considerations and treatment patterns of antihyperglycemic agents for diabetic nephropathy: a review of the literature.
    Jairoun AA; Ping CC; Ibrahim B
    Eur Rev Med Pharmacol Sci; 2023 Dec; 27(24):12058-12069. PubMed ID: 38164868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperuricemia contributes to the faster progression of diabetic kidney disease in type 2 diabetes mellitus.
    Bartáková V; Kuricová K; Pácal L; Nová Z; Dvořáková V; Švrčková M; Malúšková D; Svobodová I; Řehořová J; Svojanovský J; Olšovský J; Bělobrádková J; Kaňková K
    J Diabetes Complications; 2016; 30(7):1300-7. PubMed ID: 27324705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting inflammation for the treatment of Diabetic Kidney Disease: a five-compartment mechanistic model.
    Hofherr A; Williams J; Gan LM; Söderberg M; Hansen PBL; Woollard KJ
    BMC Nephrol; 2022 Jun; 23(1):208. PubMed ID: 35698028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inflammatory Mechanisms as New Biomarkers and Therapeutic Targets for Diabetic Kidney Disease.
    Alicic RZ; Johnson EJ; Tuttle KR
    Adv Chronic Kidney Dis; 2018 Mar; 25(2):181-191. PubMed ID: 29580582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.